Why not the 'marker' or DIVA vaccines for the control of emerging infectious diseases of humans?

Singh, Ajit

Singh, Ajit.

Singh A; Emeritus Scientist (ICAR), Department of Veterinary Microbiology, Lala Lajpat Rai University of Veterinary and Animal Sciences, Hisar 125004, India. Electronic address: as.jakhar@luvas.edu.in.

Vaccine ; 39(10): 1476-1477, 2021 03 05.

Article in English | MEDLINE | ID: covidwho-1070591

Subject(s)

Communicable Diseases, Emerging; Viral Vaccines; Communicable Diseases, Emerging/epidemiology; Communicable Diseases, Emerging/prevention & control; Humans; Vaccines, Attenuated; Vaccines, Marker

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines / Communicable Diseases, Emerging Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Vaccine Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google